Wet Age-Related Macular Degeneration In The Japanese Population Is Linked To Four Regions Of The Chromosome
January 17, 2012
Source: Riken Research
Age-related macular degeneration (AMD) is a common disease that can result in blindness. It is caused by cell death in the eye's retina, which is partly responsible for transforming visual stimuli into electrical signals to the brain. Asian populations tend to exhibit a particular type of the disease, called wet AMD, which includes changes in the blood vessels of the eye. Caucasians, however, tend to exhibit AMD without these vascular abnormalities. Now, a research team led by Michiaki Kubo at the RIKEN Center for Genomic Medicine in Yokohama has identified four genomic areas that increase the risk for wet AMD in Japanese individuals.
The researchers searched for genomic regions linked to wet AMD by investigating single-nucleotide changes in the human genome. Other research groups had previously performed this kind of genome-wide association study (GWAS) in Caucasian populations, but not in the Japanese.
Kubo and colleagues began by performing a GWAS on 800 Japanese individuals with wet AMD and 3,000 Japanese controls; they identified two genomic regions previously linked to AMD in Caucasians. This suggested to the researchers that the mechanisms underlying AMD in both populations are likely to be similar.
In a 'replication study' using 700 patients and 15,000 controls, the researchers then carefully examined 77 additional genomic areas that showed potential as candidate wet AMD-associated regions in their initial GWAS. The replication study yielded two additional genomic regions that were linked to wet AMD. One of these—on chromosome 4—covered four nearby genes, so the researchers were unable to pinpoint with certainty which of the genes were responsible for the disease risk. However, another region—on chromosome 8—was linked to the gene called TNFRSF10A, which encodes a receptor expressed in the eye that modulates inflammation and cell death.
The variant of the gene that Kubo and colleagues linked to wet AMD seemed to regulate the expression of the receptor. “We are next planning to investigate exactly how the signaling pathway initiated by this receptor would affect the development of wet AMD,” explain Kubo and Satoshi Arakawa, the study's first author.
The identification of these genomic regions that are linked to wet AMD could aid in the development of new therapies. “Our results will also help in the construction of risk prediction models for wet AMD,” say Kubo and Arakawa.
Adapted from Riken Research
View all news updates for macular degeneration
Disclaimer: The information provided in this section is a public service of the BrightFocus Foundation, and should not in any way substitute for the advice of a qualified healthcare professional, and is not intended to constitute medical advice. Although we take efforts to keep the medical information on our website updated, we cannot guarantee that the information on our website reflects the most up-to-date research. Please consult your physician for personalized medical advice; all medications and supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical product or therapy.
Some of the content in this section is adapted from other sources, which are clearly identified within each individual item of information.